Comparative Pharmacology
Head-to-head clinical analysis: PENICILLIN 2 versus VEETIDS 500.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PENICILLIN 2 versus VEETIDS 500.
PENICILLIN-2 vs VEETIDS '500'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
VEETIDS '500' (cefuroxime axetil) is a second-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby blocking transpeptidation and leading to cell lysis. It has activity against both gram-positive and gram-negative bacteria.
250 mg orally every 6 hours or 500 mg orally every 8 hours for mild to moderate infections; intravenous dosing: 1-2 million units every 4-6 hours.
1 tablet (500 mg) orally twice daily for 7 days.
None Documented
None Documented
30-60 minutes; prolonged in renal impairment (up to 10 hours in anuria)
4-6 hours (prolonged in renal impairment; requires dose adjustment if CrCl <30 mL/min)
Renal: 60-80% unchanged; biliary/fecal: minor (10-20%)
Renal: 60-80% unchanged; biliary/fecal: 15-25% as metabolites
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic